Rodger J. Pannone

Lombard Odier Asset Management (USA) Corp. (LOAM) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2000 and do-business-as Lombard Odier Investment Managers. The firm is a subsidiary of LO Holding SA and their ultimate parent is Switzerland-based Compagnie Lombard Odier SCmA. LOAM provides investment advisory services on a discretionary basis to private pooled investment vehicles (Funds) and investment advisory accounts. The investors in the Funds consist of endowments, foundations, insurance companies, high net-worth individuals, funds of funds, public and corporate pensions, and other sophisticated investors.

Itaconix Corp. operates as a bio-based specialty chemicals company that develops and produces polymers from itaconic acid. Its products include Itaconix DSP, CHT, Velasoft, XDP, TSI, Zinador, Biobind, and Biolift. The company was founded by John R. Shaw and Yvon Durant in 2008 and is headquartered in Stratham, NH.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Davol, Inc. manufactures medical and surgical instruments. The company also provides hernia repair, homeostasis, laparoscopy, hysteroscopy, wound management and orthopedics. Davol was founded in 1874 and is headquartered in Cranston, RI.

The Association of Greater Manchester Authorities provides support services.

The Medical Protection Society Ltd. is a non-profit organization, which engages in the provision of legal services for medical professionals. It offers assistance with clinical negligence claims, complaints, medical and dental council inquiries, legal and ethical dilemmas, disciplinary procedures, inquests, and fatal accident inquiries. The company was founded in 1892 and is headquartered in London, the United Kingdom.

Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom.

Zeneca Pharmaceuticals manufactures medicines.

Alkalon A/S engages in the development of pharmaceutical industry. It focuses on developing and commercializing medicated chewing gum formulations. The firm also owns portfolio of nicotine gums approved for smoking cessation and smoking reduction. The company was founded by Bo Tandrup in 2007 and is headquartered in Copenhagen, Denmark.

IOmet Pharma Ltd. develops drugs and related products. It focuses on developing the novel ideas sourced from universities, research institutes and industry as well as internally generated programs. The company was founded by Peter Trill and Tom Brown in 2010 and is headquartered in Scotland, the United Kingdom.

Institute of Directors In Ireland promotes governance and develops leadership skills. It offer services to boards in Ireland including a non-executive director and chairperson appointment service through the boardroom centre, a board evaluation service, carried out by highly experienced assessors. The company is headquartered in Dublin, Ireland.

The Institute of Directors (United Kingdom) is a community of passionate UK business leaders. The non-profit company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The British company provides professional training opportunities and access to essential help and resources for its members. The CEO of the company is Stephen Martin.

Ovarian Cancer Action is a non-profit organization which supports women who are affected by ovarian cancer. The company was founded by Allyson Kaye in 2005 and is headquartered in London, the United Kingdom.

The Foulkes Foundation operates as a charitable foundation. It provides medical research, training of scientists, and the study of medicine. The company was founded by Ernest Foulkes in 1972 and is headquartered in London, the United Kingdom.

Nc3rs operates as a scientific non-profit organization dedicated to replacing, refining, and reducing the use of animals in research and testing. The firm collaborates with scientists and organizations from across the life sciences sector including universities, the pharmaceutical, chemical, and consumer products industries, other research funders, and regulatory authorities. The company is headquartered in London, the United Kingdom.

Cheadle Hulme School is an independent school located in Cheadle, UK. The school offers Sixth Form Pathways to meet the needs of students with specific career ambitions and provides them with skills and experiences. The school has a High-Performance Programme that is awarded to pupils who show academic, sporting, or musical potential and the drive and commitment to succeed. The school is proud of its relationships with former pupils and staff, known as Old Waconians (OWs). The school provides an outstanding and inspiring education to pupils, helping them to fulfill their potential to flourish in the world. The school was founded in 1855 to provide education for orphans and poor children of warehousemen and clerks.

NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom.

Blueberry Therapeutics Ltd. engages in the development of innovative medicines. It offers nanomedicine, anti infection and anti microbial, anti inflammatory bowel diseases, acne, dermatitis and wound medicines. The company was founded by John Ridden and Mike Davies and is headquartered in Macclesfield, the United Kingdom.

KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom.

NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology.